The QualityStocks Daily Stock List
- The American Energy Group, Ltd. (AEGG)
- Innovation Pharmaceuticals, Inc. (IPIX)
- BioRestorative Therapies, Inc. (BRTX)
- Viking Energy Group, Inc. (VKIN)
- TechPrecision Corp. (TPCS)
- Anvia Holdings Corporation (ANVV)
- U.S. Stem Cell, Inc. (USRM)
- Aspen Group, Inc. (ASPU)
- IGEN Networks Corp. (IGEN)
- MedMen Enterprises, Inc. (MMNFF)
- FogChain Corp. (FOGCF)
- Akbank T.A.S. (AKBTY)
The American Energy Group, Ltd. (AEGG)
Zacks, Penny Stock Tweets, Stockwatch, Dividend Investor, Real Investment Advice, InvestorsHub, Stockhouse, 4-Traders, GuruFocus, The Street, MarketWatch, Wallet Investor, Marketbeat, Research Gate, Market Screener, and Business Wire reported on The American Energy Group, Ltd. (AEGG), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
The American Energy Group, Ltd. (AEGG) is an energy resource royalty company. It is a non-operating oil and gas organization. AEGG has an 18 percent gross overriding royalty interest on the producing Yasin Block 2468-7 in South-Central Pakistan that comprises 539,172 acres. OTCQB-listed, AEGG has its corporate office in Westport, Connecticut.
The Company’s other core assets comprise royalties and convertible carried working interests (WI’s) in oil and gas leases. These include a 2.5 percent carried working interest (WI) in Zamzama North Block No. 2667-8 under exploration in South-Central, Sindh Province, Pakistan. Heritage Oil and Gas is the operator. This property consists of 557,951 square acres.
Additionally, in the Zamzama North and Sanjawi Blocks, AEGG has the option to convert its 2.5 percent carried WI’s at any time, on a well by well basis to a 1.5 percent royalty, free of the costs of exploration and development of the leases. The convertible carried WI is "carried", which means free of exploration and development costs, as to the first three wells for Zamzama North, and the first two wells for Sanjawi.
AEGG also has a 2.5 percent carried WI in Sanjawi Block No. 3068-2 under exploration in North-Central, Baluchistan Province, Pakistan. Heritage Oil and Gas is the operator. This property is 302,895 square acres. The other joint venture (JV) partners are Hycarbex-American Energy, Inc, Sprint Energy, and Trakker Energy.
AEGG’s strategy is to expand its portfolio of royalty and convertible WI’s in long-term petroleum leases. Moreover, the Company’s strategy is to create shareholder value through investing in exploration and early development projects with high cash-flow potential. The Company’s focus will be high-impact, South Asia energy development opportunities that are characterized by manifold target structures and locations with a potential for considerable hydrocarbon reserves.
Last week, AEGG announced that the International Chamber of Commerce (ICC) 3-Arbitrator panel issued its unanimous Final Award dated as of August 31, 2018 completing the ICC Arbitration proceeding that AEGG started in 2012 against the purchasers of the stock of its subsidiary, Hycarbex-American Energy, Inc.
The Final Award decrees Hycarbex Asia Pte. Ltd. pay to AEGG £406,676.74 as reimbursement for legal fees and costs; Hycarbex Asia Pte. Ltd. pay to AEGG US$597,100 as reimbursement for the costs of arbitration; and Hycarbex Asia Pte. Ltd. return to AEGG 1.5 million of the Company’s common shares, or if such shares are no longer held by Hycarbex Asia Pte. Ltd., authorizing the cancellation of the shares. Furthermore, the ICC authorized a refund by the ICC to AEGG of US$212,000 in filing and hearing fees deposited with the ICC. Hycarbex Asia Pte. Ltd. is now in liquidation proceedings in Singapore.
The American Energy Group, Ltd. (AEGG), closed Monday's trading session at $0.0746, even for the day, on 15,300 volume with 2 trades. The average volume for the last 3 months is 16,123 and the stock's 52-week low/high is $0.025/$0.0476.
Innovation Pharmaceuticals, Inc. (IPIX)
The OTC Reporter, TipRanks, Insider Financial, Stockopedia, Emerging Growth, Stockdigest Report, MarketWatch, Wallet Investor, Investors Hangout, Barchart, Streetwise Reports, Real Investment Advice, Simply Wall St, Stockhouse, and InvestorsHub reported on Innovation Pharmaceuticals, Inc. (IPIX), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Innovation Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It is developing unique therapies in numerous diseases. Its belief is that it has a premier portfolio of first-in-class lead drug candidates. The Company is currently advancing them toward market approval, while actively seeking strategic partnerships. OTCQB-listed, Innovation Pharmaceuticals is headquartered in Beverly, Massachusetts.
The Company has established research collaborations with world-renowned research institutions in the U.S. and Europe. These include MD Anderson Cancer Center, Beth Israel Deaconess Medical Center, and the University of Bologna.
Innovation Pharmaceuticals’ anti-cancer drug is Kevetrin. It successfully concluded a Phase 1 clinical trial at Harvard Cancer Centers’ Dana Farber Cancer Institute and Beth Israel Deaconess Medical Center. The Company has started a Phase 2 study in Ovarian Cancer.
Innovation has its Phase 2 clinical trial with its novel compound Brilacidin-OM for the prevention of OM in patients with head and neck cancer. Brilacidin, which is a defensin mimetic compound, has shown in an animal model to reduce the occurrence of severe ulcerative Oral Mucositis (OM) by greater than 94 percent versus placebo.
Brilacidin completed a Phase 2b trial for Acute Bacterial Skin and Skin Structure Infection, or ABSSSI. Top-line data have shown a single dose of Brilacidin to deliver comparable clinical outcomes to the Food and Drug Administration (FDA)-approved seven-day dosing regimen of daptomycin.
The Company’s Psoriasis drug candidate is Prurisol. It completed a Phase 2 trial and Innovation has launched a Phase 2b study. Prurisol is a small molecule. It acts via immune modulation and PRINS reduction.
Innovation announced this past May that it concluded its review of all data outputs and corresponding analyses from its successfully completed Phase 2 Brilacidin-OM trial for the indication of decreasing the incidence of Severe Oral Mucositis (Severe OM) (WHO Grade ≥3) in Head and Neck Cancer (HNC) patients receiving chemoradiation. Important efficacy outcomes were reduced incidence of severe OM (Primary Endpoint); delayed onset of severe OM (Secondary Endpoint); and reduced duration of severe OM (Secondary Endpoint).
Earlier this month, Innovation Pharmaceuticals announced that it has been invited to present on the planned continued development of Brilacidin for Inflammatory Bowel Disease at the inaugural “IBD Innovate 2018” conference. The day-long conference, hosted by the Crohn’s & Colitis Foundation and sponsored, in part, by Celgene Corporation, will take place on November 13, 2018, at the New York Academy of Medicine located in New York, New York.
Innovation Pharmaceuticals, Inc. (IPIX), closed Monday's trading session at $0.27, down 6.90%, on 533,946 volume with 139 trades. The average volume for the last 3 months is 220,777 and the stock's 52-week low/high is $0.227/$1.169.
BioRestorative Therapies, Inc. (BRTX)
Streetwise Reports, Zacks, Stockhouse, Marketbeat, Capital Cube, Pink Investing, Proactive Investors, Simply Wall St, MarketWatch, Barchart, Stockopedia, GuruFocus, Investor Ideas, Corporate Information, 4-Traders, Market Screener, InvestorsHub, and ProActive Capital reported on BioRestorative Therapies, Inc. (BRTX), and we also report on the Company, here at the QualityStocks Daily Newsletter.
BioRestorative Therapies, Inc. is a life sciences company focusing on adult stem cell-based therapies for varied personal medical applications. The Company develops products and medical procedures using cell and tissue protocols, mainly involving adult stem cells. BioRestorative Therapies has its corporate, administrative, and laboratory operations in Melville, New York. The Company’s shares trade on the OTCQB.
BioRestorative Therapies’ aim is to become a leader in providing medical procedures utilizing cell and tissue protocols, primarily involving adult stem cells (non-embryonic), and allowing patients to undergo minimally invasive cellular-based treatments. It is developing a cell-based therapy to target obesity and metabolic disorders utilizing brown adipose (fat) derived stem cells to produce brown adipose tissue (BAT). The intention of BAT is to mimic naturally occurring brown adipose depots, which regulate metabolic homeostasis in humans.
BioRestorative Therapies’ lead cell therapy candidate is BRTX-100. This product is formulated from autologous (or a person’s own) cultured mesenchymal stem cells collected from the patient’s bone marrow.
The Company’s products and medical procedures include brtxDISC™ (Disc Implanted Stem Cells), its Disc/Spine Program, and also ThermoStem®, its Metabolic Program. brtxDISC™ is an investigational non-surgical treatment for bulging and herniated lumbar discs. brtxDISC™’s intention is for patients who have failed non-invasive procedures and face the prospect of surgery.
ThermoStem® is a treatment using brown fat stem cells. ThermoStem® is under development for metabolic disorders. This includes diabetes and obesity.
BioRestorative Therapies is also the beneficiary of a patent granted for a licensed curved needle device (CND). The design of it is to deliver cells and/or other therapeutic products or material to a site having damage in need of facilitated repair.
Last month, BioRestorative Therapies announced that the Journal of Translational Medicine published the results of the Company’s study evaluating the benefits of long-term hypoxic (low oxygen) culturing of human bone marrow-derived mesenchymal stem cells (cells used in BioRestorative’s product, BRTX-100). The study included data on cell fitness and whole genome expression. The study discussed its implication on cellular therapies targeting intervertebral discs and its microenvironment.
The study demonstrated that, versus cells cultured under normal atmospheric conditions (normoxic), hypoxic culturing improves mesenchymal stem cell properties and positively influences whole genome expression profiles regarding the development of cellular therapies targeting the microenvironment of the intervertebral disc.
BioRestorative Therapies, Inc. (BRTX), closed Monday's trading session at $1.58, up 1.94%, on 65,326 volume with 82 trades. The average volume for the last 3 months is 62,547 and the stock's 52-week low/high is $1.029/$4.00.
Viking Energy Group, Inc. (VKIN)
FatCat Stocks, Wall Street Beauties, WINNINGOTC, SMS Penny Picks, Greenbackers, SmallCapFinancialWire, Daily Stock Motion, Penny Pick Insider, Penny Stocks VIP, and Undiscovered Equities reported earlier on Viking Energy Group, Inc. (VKIN), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Established in 1989, Viking Energy Group, Inc. is an independent exploration and production corporation. The Company targets under-valued assets with realistic appreciation potential. Viking Energy owns oil and gas leases in Kansas, Missouri, and Texas, Louisiana, Mississippi and Alberta. The Company is based in New York, New York. Viking Energy Group lists on the OTC Markets’ OTCQB.
The Company previously went by the name Viking Investments Group, Inc. It changed its name to Viking Energy Group, Inc. in March of 2017.
In essence, Viking Energy purchases interests in producing, long-life, low-cost oil properties producing positive cash-flow. It is not considering speculative exploration programs.
The Company targets properties with current production and untapped reserves for future benefit. Viking Energy concentrates on acquiring under-valued, producing properties from distressed vendors or those considered as non-core assets by larger sector participants.
Viking Energy, via its wholly-owned subsidiary, Mid-Con Petroleum, LLC, owns a working interest in 7 producing oil leases with access to the mineral rights (oil and gas) regarding roughly 800 acres of property in Miami and Franklin Counties in Eastern Kansas. Its working interests (WI’s) in the leases range from 68 percent to 100 percent.
In Alberta, Viking Energy has a Joint Venture (JV) with Tanager Energy, Inc. The Company’s investment with Tanager Energy includes a 50 percent WI in the Joffre Project, comprising 4 oil wells and one water injection well. Tanager Energy’s initial project incorporates the Leduc D-3 B Pinnacle Reef in Central Alberta, which is where the Joffre D-3 Oil Project is situated (the Joffre Project).
In Missouri, Viking Energy owns a 100 percent W1 (approximately NRI 83 percent) in 31 leases, with access to the mineral rights (oil and gas) concerning approximately 5,500 acres of property in Cass and Bates Counties. Viking Energy has acquired additional working interests in an assortment of oil and gas-related leases in Eastern Kansas. On September 11, 2017, the Company, through a wholly-owned subsidiary, Mid-Con Drilling, LLC, acquired a 90 percent WI in four new oil and gas leases in Anderson County in Eastern Kansas, comprising about 980 acres of property.
Viking Energy Group announced in October 2017 that it acquired additional WI’s in different oil and gas-related leases in Kansas. This was its third acquisition in less than 30 days. On October 4, 2017, the Company, via Mid-Con Drilling, acquired, effective September 1, 2017, an 80 percent WI in six new oil and gas leases in Riley, Geary, and Wabaunsee Counties in Kansas.
This past January, Viking Energy Group announced that it acquired, via its wholly-owned subsidiary, Mid-Con Development, a majority working interest in a number of oil leases in Ellis and Rooks Counties in Kansas. Features of the acquired assets include more than 40 oil leases, consisting of roughly 3,300 acres. Cumulative oil production from the acquired leases is greater than 6,400,000 barrels. Haas Petroleum LLC has been engaged to operate the assets on behalf of Mid-Con. Haas Petroleum is a fourth-generation oil and gas company.
Viking Energy Group, Inc. (VKIN), closed Monday's trading session at $0.37, up 15.62%, on 271,590 volume with 60 trades. The average volume for the last 3 months is 55,880 and the stock's 52-week low/high is $0.09/$0.34.
TechPrecision Corp. (TPCS)
Stock Rich, Marketbeat.com, TopPennyStockMovers, Zacks, StreetInsider, Energy and Capital, Wealth Daily, FeedBlitz, SmallCapVoice, BullRally, HotOTC, CoolPennyStocks, PennyStockVille, MadPennyStocks, and Stock Market News Alert reported beforehand on TechPrecision Corp. (TPCS), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
TechPrecision Corp., through its wholly-owned subsidiaries, Wuxi Critical Mechanical Components Co., Ltd., and Ranor, Inc., is an industry leading manufacturer of precision, large-scale fabricated and machined metal components and tested systems. The Company’s goal is to be an end-to-end international service provider to its customers through furnishing customized and integrated turn-key solutions for completed products necessitating custom fabrication and machining, assembly, inspection, and testing.
OTCQB-listed, TechPrecision has its head office in Westminster, Massachusetts. The Company’s subsidiary companies have facilities in the U.S. and China. TechPrecision’s products are used in the alternative energy, medical, nuclear, defense, and precision industrial, aerospace, and naval/maritime markets, among others.
The Company has the fabrication capacity to see a client’s large-scale components through from initial processing to final finishing and assembly. This eliminates the need for outside servicing. In addition, it helps ensure lower costs.
TechPrecision’s Ranor subsidiary specializes in large-scale, precision component fabrication for the Clean Technology, Energy, Medical, Aerospace, and Defense sectors. Ranor’s capabilities encompass Production Control; Engineering; Processing; Fabrication; Machining; Assembly & Finishing; Quality Assurance, and NDE & Inspection.
The design of TechPrecision’s Wuxi Critical Mechanical Components (CMC) subsidiary is to meet the growing global demand for an experienced, knowledgeable machining and distribution center in Asia, providing large-scale component fabrication solutions for the region's wind power and solar challenges.
CMC utilizes one of the largest forges in the industry. CMC’s capabilities include Forging; Fabrication; Machining; Inspection; Assembly & Finishing, and Quality Assurance. CMC serves the Solar/LED; Wind; Nuclear; Clean Technology, Medical; and General Industrial industries.
In February, TechPrecision reported financial results for Q3 and the nine months ended December 31, 2017. Net Sales for the three months ended December 31, 2017 were $3.6 million. This represents a 32 percent decrease versus the same quarter a year prior.
Net Sales for the nine months ended December 31, 2017 were $14.1 million. This represents a 3 percent increase versus the same period a year prior. The Company’s Sales order backlog at December 31, 2017 was $11.2 million versus a backlog of $15.8 million at March 31, 2017.
Mr. Alexander Shen, Chief Executive Officer of TechPrecision, said, "Our third quarter results were impacted by two factors: first, defense customer appropriations and funding delays resulted in lower order volume, and second, a higher mix of lower margin shipments. We expect a strong pipeline of business ahead, once the appropriations and funding delays are resolved. As of today, we have in place certain agreements which release funding for materials acquisition in advance of new orders to build components for a number of our key customers."
TechPrecision Corp. (TPCS), closed Monday's trading session at $0.77, up 0.65%, on 57,900 volume with 23 trades. The average volume for the last 3 months is 30,011 and the stock's 52-week low/high is $0.4602/$0.7799.
Anvia Holdings Corporation (ANVV)
Stockhouse, Stock Orange, OTC Markets, 4-Traders, GuruFocus, Stockwatch, Penny Stock Hub, High Rising Stocks, Wallmine, Investors Hangout, Street Insider, Jet Life Penny Stocks, Stockopedia, Barchart, Morningstar, TradingView, and Simply Wall St reported on Anvia Holdings Corporation (ANVV), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Anvia Holdings Corporation is a global technology company listed on the OTC Markets’ OTCQB. Anvia is a worldwide technology enterprise that creates comprehensive, turnkey software and consulting solutions for small to medium-sized businesses. In addition, it is the world’s complete eco-system for tradesmen in the construction industry. The Company’s businesses serve the complete lifecycle of tradesmen or handymen in the construction industry. The Company works to build competent tradesmen for the construction industry and make them accessible to the market. Anvia Holdings is based in Glendale, California.
Anvia is the first integrated platform for blue-collar workers in the construction industry to provide qualification, licensing, continuous education, placement services, entrepreneurship opportunities, and cash-back or loyalty programs in Australia and worldwide. The Company has its Anvia College. This College offers quality and world-class education services and products to its aspiring tradesmen and construction workers in a blended learning environment. Anvia College provides essential qualification courses related to the construction environment.
Additionally, Anvia Holdings offers its Anvia Loyalty. This is a free loyalty program by the Company designed for existing qualified and aspiring tradesmen. Anvia Loyalty is a single platform. It connects the Company’s members to all Anvia products and services.
Furthermore, Anvia Holdings has its Anvia Recruiters. Anvia Recruiters provides employment services to graduates of Anvia College and Anvia members internationally. The Company also has its Anvia Market. Anvia market is an online store for tradesmen or handymen involved in the construction industry to buy safety wear and tools.
In May, Anvia Holdings announced that it fully acquired Anvia (Australia) Pty Ltd, previously known as Kasa Corporation (Australia) Pty Ltd. Anvia (Australia) Pty Ltd is fully-owned subsidiary of Anvia Holdings. Anvia Australia commercializes Anvia’s intellectual property (IP) assets. These assets include Anvia Learning, Anvia Market, Anvia Recruiters and Anvia Loyalty in the Australian Market.
Anvia (Australia) Pty Ltd announced this past June that it acquired all of the issued and outstanding shares of Global Institute of Vocational Education Pty Ltd (Melbourne, Australia). Global Institute of Vocational Education is a Registered Training Organization (RTO) under Australian Qualification Framework (AQF) by Australian Skills Quality Authority (ASQA).
Recently, Anvia Holdings announced that it completed the first stage of due diligence of All Crescent Sdn Bhd and its subsidiaries. On March 22, 2017, Anvia entered into a non-binding preliminary agreement with All Crescent. Under the terms of the proposed All Crescent acquisition and its subsidiaries, Anvia agreed to pay a consideration of $200,000 in exchange for obtaining a 51 percent equity stake in All Crescent and provide an additional $500,000 as cash or shares in Anvia Holdings Corporation to allow All Crescent to acquire the remaining 49 percent shares and provide liquidity for the business activities.
Anvia Holdings Corporation (ANVV), closed Monday's trading session at $1.10, even for the day, on 1,000 volume with 2 trades. The average volume for the last 3 months is 1,002 and the stock's 52-week low/high is $0.5099/$1.70.
U.S. Stem Cell, Inc. (USRM)
TradingView, InvestorsHub, MarketWatch, and Money Morning reported on U.S. Stem Cell, Inc. (USRM), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
U.S. Stem Cell, Inc. is a developing business in the regenerative medicine/cellular therapy industry. The Company is a developer of novel autologous cell therapies, and a provider of physician based stem cell therapies to human and animal patients. U.S. Stem Cell has three operating divisions: US Stem Cell Training, Vetbiologics, and US Stem Cell Clinic. U.S. Stem Cell is headquartered in Sunrise, Florida. The Company previously went by the name Bioheart, Inc. It changed its corporate name to U.S. Stem Cell, Inc. in October 2015.
The Company’s focus is on the discovery, development, and commercialization of cell based therapeutics, which prevent, treat, or cure disease through repairing and replacing damaged or aged tissue, cells and organs and restoring their normal function.
U.S. Stem Cell’s business includes the development of proprietary cell therapy products and revenue generating physician and patient based regenerative medicine/cell therapy training services. Its business additionally includes cell collection and cell storage services, the sale of cell collection and treatment kits for humans and animals, and the operation of a cell therapy clinic.
U.S. Stem Cell’s lead product candidate is MyoCell®. This is a muscle stem cell therapy intended to improve cardiac function months or even years after a patient has suffered severe heart damage because of a heart attack.
MyoCell SDF-1 has received approval from the Food and Drug Administration (FDA) to begin human clinical trials. The intention of MyoCell SDF-1 is to be an improvement to MyoCell. Concerning its AdipoCell product, the Company has applied to the FDA to begin trials using adipose derived stem cells or AdipoCell™ in patients with chronic ischemic cardiomyopathy.
U.S. Stem Cell announced has developed a strategic alliance with Advanced Stem Cell Rx (ASC). This includes the development of autologous stem cell treatment centers across the U.S. ASC is a U.S. based provider of regenerative medicine programs.
This past January, U.S. Stem Cell announced it reached an important milestone of 10,000 kit sales of its proprietary Adipocell™ product. This is a direct result of the Company’s relationships with 287 clinics in the U.S. and 700-plus physicians globally offering the Company’s proprietary stem cell products and services.
Recently, U.S. Stem Cell announced that it is experiencing great demand for stem cell treatments at its clinics. This is a trend reflected in the 106 percent increase in Revenues during Q3. This is continuing due to rapidly growing demand from the marketplace.
U.S. Stem Cell, Inc. (USRM), closed Monday's trading session at $0.02895, up 21.54%, on 1,879,227 volume with 65 trades. The average volume for the last 3 months is 1,355,658 and the stock's 52-week low/high is $0.01759/$0.08799.
Aspen Group, Inc. (ASPU)
TheMicrocapNews, Greenbackers, TaglichBrothers, Stock News Now, and RedChip reported earlier on Aspen Group, Inc. (ASPU), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Aspen Group, Inc. is a for-profit post-secondary education company. Aspen Group owns two accredited universities. These are Aspen University and United States University. Aspen Group is headquartered in New York, New York. The Company lists on the OTC Markets Group’s OTCQB.
The mission of Aspen University is to offer any motivated college-worthy student the opportunity to receive a high quality, responsibly priced distance-learning education to realize sustainable economic and social benefits for themselves and their families. Aspen University’s dedication is to provide the highest quality education experiences taught by top-tier faculty. Of note is that 54 percent of Aspen University’s faculty hold doctoral degrees.
Degrees offered by Aspen University include Associates, Bachelor’s, Master’s, Doctoral, and Certificates. Aspen University has its School of Professional Studies, School of Nursing, School of Education, School of Management, School of Information Technology, and College of Arts and Sciences.
United States University started its institutional history in 1997 as InterAmerican College in National City, California. The school was renamed to United States University in 2010.
United States University recently moved its campus into the heart of San Diego, California. It is regionally accredited by the Accrediting Commission for Senior Colleges and Universities of the Western Association of Schools and Colleges. United States University offers Bachelor and Master level degree programs in nursing, education, health science, as well as business & management.
In July of 2017, Aspen Group announced Aspen University’s launch of the Doctor of Nursing Practice (DNP) in Leadership online degree program. The design of the DNP degree is to be a practice-centered program that combines a scholarly approach to the discipline of nursing. The program prepares advanced practice nurses and educators to lead their organizations and the next generation of nurses.
Aspen Group will host a conference call to discuss its Fiscal Year 2018 Q3 (ending January 31, 2018) financial results and business outlook today - March 15, 2018. The Company will issue a press release reporting results after the market closes today.
Aspen Group, Inc. (ASPU), closed Monday's trading session at $7.00, up 1.60%, on 17,639 volume with 170 trades. The average volume for the last 3 months is 55,195 and the stock's 52-week low/high is $5.8499/$9.6099.
IGEN Networks Corp. (IGEN)
NetworkNewsWire.com, MarketWatch, InvestorsHub, Marketwired, OTC Markets, Information Vine, Business Insider, Stock Press Daily, The Street, and Barchart reported on IGEN Networks Corp. (IGEN), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
IGEN Networks Corp. is a foremost innovator of cloud-based and Internet of Things (IoT) automotive solutions for the protection and management of mobile assets. The Company provides peace-of-mind to automotive consumers and their families via direct access to IoT cloud-based services, which include Stolen Vehicle Protection, Real-time updates on asset health and Driver Behavior. OTCQB-listed and incorporated in 2006, IGEN Networks has its head office in Murrieta, California.
The Company provides vehicle tracking and recovery solutions to the automotive dealership industries in the U.S. IGEN Networks serves the automobile industry through vehicle security services, lot management services, and driver behavior services.
IGEN Networks enables automotive dealer channels to provide new products, create additional revenue streams, as well as keep their customers. The Company provides peace-of-mind to consumers through providing direct access to vehicle status and driver behavior. The Company also enables insurance companies to decrease their rating errors through offering consumers discounted premiums in return for access to vehicle and driver behavior data.
This past October, IGEN Networks announced the launch of Medallion GPS™. Medallion GPS™ is a new, easily installed, direct-to-consumer solution. It combines vehicle agnostic hardware with cloud based smartphone software. This system provides automotive aftermarket customers with a new standard in stolen vehicle recovery support, vehicle systems alerts, driver behavior monitoring and GPS tracking capabilities, in addition to other features.
In November, IGEN Networks announced the filing of its Q3 2017 financial results. The Company increased year-to-date Revenue 26 percent to 1.04 million, boosted by growing adoption of its mobile asset tracking platforms. It grew the subscriber base 264 percent year-over-year, to over 31,000 assets at September 30, 2017.
IGEN increased deferred revenue 146 percent, to $182,000. The Company increased gross margin to 39.2 percent through the first nine months, versus 36.8 percent in the previous year period. It reported a Net Loss of $662,000 year-to-date, excluding stock based compensation expenses, versus $551,000 in the previous year nine-month period.
IGEN Networks Corp. (IGEN), closed Monday's trading session at $0.0521, up 3.41%, on 149,700 volume with 14 trades. The average volume for the last 3 months is 39,090 and the stock's 52-week low/high is $0.035/$0.14.
MedMen Enterprises, Inc. (MMNFF)
OTC Markets, The Street, Wallmine, TradingView, Barchart, Stockwatch, OTC Stock Picks, New Cannabis Ventures, Penny Stock Hub, OTC Stock Watch, Stockhouse, 4-Traders, Morningstar, Insider Financial, MarketWatch, Daily Marijuana Observer, Investors Hangout, Investing News, and GuruFocus reported on MedMen Enterprises, Inc. (MMNFF), and we report on the Company as well, here at the QualityStocks Daily Newsletter.
MedMen Enterprises, Inc. brings expertise and capital to the cannabis industry. The Company is one of the nation’s largest financial supporters of progressive marijuana laws. MedMen Enterprises owns and operates 18 facilities covering the entire vertical from cultivation to manufacturing to retail in three key states - California, Nevada and New York. MedMen Enterprises is based in Los Angeles, California.
The Company’s professional team consists of cannabis experts, retail experts, marketing experts, financing experts, regulatory affairs experts, and agricultural and operations experts. MedMen Enterprises manages class leading retail stores that sell marijuana and marijuana products.
MedMen operates several dispensaries in the most strategic markets in the nation. It has a fast-growing footprint. This includes expansion plans in other important states and also Canada.
The Company has added ground cannabis flower to its product offerings in the State of New York. Presently, MedMen stores in New York offer vaporizer pens, tinctures and gel caps in five different formulations. The addition of ground flower will give its New York medical marijuana patients more product choices in the State’s fast developing market.
MedMen Enterprises has a total of three stores planned for Las Vegas, Nevada. This includes one on Paradise Road, near the Hard Rock Hotel and the Las Vegas International Airport, which recently won county approval. The Company recently announced its expansion into a fourth key market, Florida, through a proposed acquisition of dispensary and cultivation assets from Treadwell Simpson Partnership and affiliates.
Earlier this month, MedMen Enterprises announced it secured prime retail locations with long term leases in Ft. Lauderdale, Miami Beach, West Palm Beach, St. Petersburg and Key West. MedMen continues to expand its footprint in first-rate retail districts with high visibility and heavy foot traffic.
Moreover, the Company completed the transaction it announced on June 6, 2018, acquiring a dispensary and cultivation license and related assets from Florida based Treadwell Simpson Partnership and affiliates (Treadwell Nursery). The License allows MedMen to open 30 (and up to 35 if certain conditions are met) medical marijuana dispensaries in Florida and to conduct cultivation, delivery and manufacturing operations in Florida. As part of the transaction, MedMen Enterprises also acquired Treadwell Nursery’s cultivation facility located on five acres near Orlando.
MedMen Enterprises, Inc. (MMNFF), closed Monday's trading session at $4.5015, down 2.35%, on 641,348 volume with 1,700 trades. The average volume for the last 3 months is 560,404 and the stock's 52-week low/high is $2.609/$5.449.
FogChain Corp. (FOGCF)
Insider Financial, Stock Orange, Stockwatch, Bullish Guru, Penny Stock Hub, PressReader, StockReads, 4-Traders, OTC Markets, InvestorsHub, MarketWatch, Barchart, Investors Hangout, Stockhouse, TradingView, Market Screener, and Wallet Investor reported on FogChain Corp. (FOGCF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
FogChain Corp. is a fully integrated, end-to-end software development life cycle (SDLC) and quality assurance solutions provider. The Company’s set of services and technology provides application development at scale with more speed, efficiency and at a lesser cost. FogChain's Build-Once Deploy-Everywhere software architecture provides developers with a set of tools and resources that bridges devices, operating systems, and the ability to build and launch new applications in a unified environment. FogChain has its head office in Vancouver, British Columbia.
The Company earlier acquired RadJav, which provides developers with fast application development tools and resources for the creation of mobile and web apps, smart contracts, and dApps. These are to be used across all major operating systems and devices on a unified platform.
Recently, FogChain acquired Quilmont - a growing and profitable software development solutions provider specializing in automated testing, Continuous Integration and Deployment (CI/CD), mobile and website development, and software quality assurance. Quilmont is getting ready to release the latest version of its patented Test Case Manager platform. This is an enterprise-grade, automated application testing product, used across mobile, web, and desktop applications. Furthermore, Quilmont is working on a configurable CI/CD environment for streamlining the development of mobile applications.
Last week, FogChain announced that its rapid application development platform, RadJav, has finalized its integration with Google’s Chrome DevTools (CDT). RadJav completed the integration with Chrome DevTools - a set of web developer tools built directly into the Google Chrome browser. Chrome DevTools helps developers diagnose problems fast. This ultimately helps one write cleaner code and build better websites, faster.
Fundamentally, FogChain provides a next generation platform. This platform seamlessly integrates application development and deployment, which leverages a high-performance Fog (or Edge) based computing network to drive scale and connects with the innovative and ground-up built RadJav Blockchain. The Company is introducing the next generation of decentralized compute to the world of software development and application lifecycle management.
Fog Computing uses decentralized and distributed computing resources and application services that are closer to the Edge, or actual point of use. Fog Computing integrates with the most contemporary technologies. These include IoT (Internet of Things), BlockChain, 3D & Virtual Reality engines, and analytics tools. It can leverage underutilized resources, reducing costs.
FogChain Corp. (FOGCF), closed Monday's trading session at $0.2554, down 3.59%, on 89,096 volume with 66 trades. The average volume for the last 3 months is 31,115 and the stock's 52-week low/high is $0.173/$0.3639.
Akbank T.A.S. (AKBTY)
OTC Markets, Zacks, Amigo Bulls, MarketWatch, Morningstar, Stockhouse, Marketbeat, YCharts, Market Screener, Research Pool, StockInvest, 4-Traders, Corporate Information, Guru Focus, Capital Cube, Ticker Report, and Wallet Investor reported on Akbank T.A.S. (AKBTY), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Listed on the OTCQX, Akbank T.A.S. is Turkey’s second-largest bank by market value. On January 30, 1948, Akbank was founded as a privately-owned commercial bank in Adana. It opened its first branch in the Sirkeci district of Istanbul on July 14, 1950. The Bank has a domestic distribution network of 800 branches and greater than 14,000 employees. Akbank has its corporate headquarters in Istanbul, Turkey.
The Bank’s main business is banking activities, comprising corporate and investment banking, commercial banking, SME banking, consumer banking, payment systems, treasury transactions and private banking, and global banking services. Akbank also carries out insurance agency operations by way of its branches on behalf of Ak Insurance and AvivaSA Pensions and Life Insurance.
Along with providing its services via its branches, Akbank serves over 16.5 million customers through the Akbank Direkt Internet Branches, Akbank Direkt Mobile, the Call Center, 4,400 ATMs and over 510,000 POS terminals and other high technology channels. The Bank conducts overseas operations via its subsidiary in Germany (Akbank AG) and a branch in Malta. Its other subsidiaries, Ak Investment, Ak Asset Management and Aklease, provide non-banking financial services alongside capital markets and investment services.
As of end-2017, Akbank reported a Net Profit of TL 6 billion (approximately USD 1.6 billion), and Total Consolidated Assets of TL 342 billion (approximately USD 91.3 billion). Its capital adequacy ratio according to Basel III standards is one of the highest in the sector at 15.8 percent.
Akbank has attained significant success in the “Europe Investor Relations Survey” of Extel Surveys, well known with its global surveys performed in the field of investor relations for the last 45 years. As a result of the Extel Europe 2018 survey, Akbank was deemed worthy of three of the four prizes awarded in “The Best Investor Relations in Turkey” category.
Mr. Hakan Binbaşgil, Akbank’s Chief Executive Officer, was chosen “Best CEO for Investor Relations in Turkey”. In addition, Akbank was chosen “The Best Corporate for Investor Relations in Turkey”. The “Best Investor Relations Professional in Turkey” title went to Ebru Güvenir, Akbank’s Senior Vice President of Investor Relations and Sustainability.
Akbank T.A.S. (AKBTY), closed Monday's trading session at $1.78, down 3.78%, on 108,217 volume with 96 trades. The average volume for the last 3 months is 460,338 and the stock's 52-week low/high is $1.6849/$5.9899.
The QualityStocks Company Corner
- BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT)
- Earth Science Tech, Inc. (ETST)
- PreveCeutical Medical Inc. (CSE: PREV) (OTC: PRVCF) (FSE: 18H)
- BLOCKStrain Technology Corp. (TSX.V: DNAX) (OTC: BKKSF)
- ChineseInvestors.com (CIIX)
- QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ)
- Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF)
- DPW Holdings, Inc. (NYSE American: DPW)
- Sugarmade, Inc. (SGMD)
- TMSR Holding Company Ltd. (NASDAQ: TMSR)
- Global Payout, Inc. (GOHE)
- Sunniva Inc. (CSE: SNN) (OTC: SNNVF)
BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT)
BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT), based in Berkeley, CA, and headquartered in Vancouver, British Columbia, is a clinical-stage biotechnology company focused on the development of targeted immunotherapy for advanced breast cancer.
BriaCell hopes to develop and market the first off-the-shelf personalized immunotherapy for the treatment of advanced breast cancer.
The results of two previous proof-of-concept clinical trials produced encouraging results in patients with advanced breast cancer. Most notably, one patient with breast cancer that had spread to other sites (metastatic cancer) responded to Bria-IMT™ with a substantial tumor shrinkage in multiple sites including the breast, the lung, soft tissues and even the brain. Similar observations have been confirmed more recently in additional patients, and BriaCell is developing BriaDX™ as a way to identify those patients most likely to respond.
BriaCell has recently completed recruitment of a Phase I/II study (NCT03066947) of Bria-IMT™, the Company’s lead product candidate, in advanced breast cancer patients showing an outstanding safety profile and excellent efficacy. BriaCell is currently enrolling advanced breast cancer patients in a combination therapy trial (NCT03328026) of Bria-IMT™ with Keytruda® (Keytruda® is a registered trademark of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.) or Yervoy® (Yervoy® is a registered trademark of Bristol-Myers Squibb Company). For further information on the Phase IIa clinical trials, please visit trial NCT03066947 and trial NCT03328026.
BriaCell’s pipeline also includes Bria-OTS™, the first off-the-shelf personalized immunotherapy for advanced breast cancer; and, a companion diagnostic product BriaDX™. By using BriaDX™ to identify and treat the patients who would most likely benefit from their immunotherapies, BriaCell expects to personalize the treatment for the patients, and bring hope to thousands of cancer patients who currently have few-to-no treatment options.
Breast Cancer Statistics
The National Cancer Institute estimates that more than 265,000 new cases of female breast cancer will be diagnosed in the U.S. during 2018, and that more than 40,000 women in the U.S. will die from the disease. Approximately 12 percent of women will be diagnosed with breast cancer at some point during their lifetime, based on 2013-2015 data.
Using its novel technology platform and strong R&D capabilities, BriaCell believes it has the opportunity to address this market, as well as have the opportunity to develop immunotherapy candidates for other cancer indications.
The global cancer immunotherapy market is expected to reach nearly USD$203 billion by 2025.
BriaCell Therapeutics Corp. (BCTXF), closed the day's trading session at $0.10, even for the day, on 1,000 volume with 1 trade. The average volume for the last 3 months is 16,726 and the stock's 52-week low/high is $0.068/$0.13869.
- Dr. William Williams, BriaCell’s President & CEO, is Featured in an Exclusive New Audio Interview at SmallCapVoice.com
- BriaCell Adds New Clinical Site To Phase IIa Study in Advanced Breast Cancer and Expands R&D Team
- BriaCell to Hold Conference Call on Key Clinical Findings; Activities
Earth Science Tech, Inc. (ETST)
CannabisNewsWire ("CNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring Earth Science Tech Inc. (OTCQB: ETST), a client of CNW that offers the highest purity and quality high-grade full spectrum cannabinoid oil on the market. To view the full publication, titled “The CBD Bonanza on the Horizon,” visit: http://cnw.fm/Hh3ot. Also today, NetworkNewsWire released a report on the company detailing how the official uplisting of Earth Science Tech to the OTCQB Venture Market (http://nnw.fm/u7doK) on September 12, 2018, comes at a time when auspicious news graces the cannabis community.
Earth Science Tech, Inc. (ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.
Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:
- Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
- Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
- KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.
Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.
In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.
The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.
Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.
Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.
The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.
Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.
Earth Science Tech, Inc. (ETST), closed the day's trading session at $0.99, up 23.75%, on 121,086 volume with 120 trades. The average volume for the last 3 months is 13,688 and the stock's 52-week low/high is $0.324/$1.62.
- CannabisNewsWire Announces Publication on Superior Hemp-Derived, CBD Formulations Ready for Global Recognition in Nutraceutical, Pharmaceutical Sectors
- Earth Science Tech, Inc. (ETST) Executes Perfect Timing for Uplisting as Feds Appear to Abandon Legal High Ground on Cannabis
- UPDATE – CannabisNewsWire Announces Publication on Novel Formulations Await Expected Titanic Growth of Cannabis-Derived Pharmaceutical and Nutraceutical Markets
PreveCeutical Medical Inc. (CSE: PREV) (OTC: PRVCF) (FSE: 18H)
PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) is celebrating the achievement of several key milestones in the development of the company’s proprietary Sol-gel program for the nasal delivery of select medications, where those medications can be expected to effectively reach the nervous system in order to accomplish their purposes in treating conditions ranging from anxiety to head concussion injuries, a company officer told market reporting outlet Proactive Investors Limited.
PreveCeutical Medical Inc. (CSE: PREV) (OTC: PRVCF) (FSE:18H), headquartered in Vancouver, British Columbia, Canada, is a health sciences company dedicated to researching and developing innovative options for preventive and curative therapies utilizing organic and Nature Identical™ products. The company is strategically staking out select positions in the medically acute areas of diabetes and obesity, pain management, neurological disorders and cancer.
PreveCeutical Medical Inc. had its beginnings in 2009 when Stephen Van Deventer, a seasoned businessman and venture capitalist, and Kimberly Van Deventer, a successful entrepreneur, met and formed a business partnership. The duo created Cornerstone Global Partners, a venture capital and business development company, and became involved in numerous ventures including building companies such as Aurora Cannabis Inc. Taking their interest in the health and wellness market further, the pair began researching how nature and science can work together to benefit health-conscious consumers. Coining and trademarking the word “PreveCeutical” – a combination of the words “preventive” and “pharmaceutical” – was a precursor to the company’s formation and incorporation in October 2015.
The company’s first product was developed in the Dominican Republic and is now marketed and distributed worldwide by PreveCeutical. It is a Caribbean Blue Scorpion venom product sold under the trade name CELLB9®. This product is an oral dilute solution infused with select peptides sourced exclusively from the blue scorpion (Rhopalurus princeps) found only in Caribbean nations. The active potentiated ingredients in CELLB9, which have been used in over 40 countries for over a decade, appear to support health at a deep, cellular level. PreveCeutical’s research team is using proprietary chemistry to generate Nature Identical™ peptides derived from natural compounds found in Caribbean Blue Scorpion venom with the goal of eventually treating, regulating and preventing cancer progression. Peptides are also being used to target an array of disease indications including metabolic disorders, pain management, cancers, cardiovascular and infectious diseases.
PreveCeutical is developing the first nose-to-brain delivery system of cannabinoids (CBDs) with a novel process that prepares insoluble drug-containing nano-micelles and successfully incorporating them into a proprietary sol-gels application, essentially creating a targeted drug delivery vehicle. Intended for use via a nasal spray, this unique formulation rapidly gels upon contact with mucosal tissue, which paves the way for direct nose-to-brain delivery. This novel application eliminates first pass metabolism (stomach, intestines, liver), potentially improving bioavailability and delivering extended time release formulations that may alleviate side effects of higher dosage therapeutics. This CBD-based patented formula is projected to be deployed in selected markets with licensed medical marijuana companies within 18 months.
PreveCeutical is working with four leading Australian research centers to develop a curative therapy for diabetes and obesity. This four-year program involves engineering a novel approach that selectively targets the gene that encodes for the protein PTP-1B, which is implicated and over-expressed in both type-2 diabetes and obesity. PreveCeutical’s gene-silencing technology would effectively “turn off” the genetic signal which leads to the over-production of this key protein molecule, bringing it back down to safe, normalized levels, and prevent the body from storing excessive fat. Diabetes kills one person every six seconds, with more than $800 billion spent globally on the disease.
Another exciting joint venture, established with Sports 1 Marketing, will focus on the therapeutic potential in the peptides and proteins connected to the Caribbean Blue Scorpion venom to potentially treat mild brain injury concussions. Developing a therapeutic product geared towards athletes who suffer from concussions could help alleviate suffering experienced by those who are affected by head trauma.
PreveCeutical Medical’s science and research team is led by Dr. Harendra (Harry) Parekh, Ph.D., who is based at the University of Queensland’s (UQ) Pharmacy Australia Centre of Excellence (PACE), and Dr. Makarand Jawadekar, Ph.D., whose 28 years of R&D experience with Pfizer Inc., is applicable in his role as chief science officer. Research collaborators include Dr. Rakesh Veedu, an emerging expert internationally in the field of molecular medicine, and Professor Grant Ramm, who is currently head of a leading medical research institute located in Brisbane, Australia.
PreveCeutical Medical is partnering with leading industry experts and companies in its quest to be a leader in the preventive health sciences sector. Its Research and Development partnership with UniQuest, the main commercialization company for the University of Queensland, provides PreveCeutical with the rights to all intellectual property arising from projects created under the agreement. PreveCeutical Medical Inc.’s management team brings an extensive portfolio of research experience, product development, deep corporate strategy and capital markets leadership to the company’s core.
PreveCeutical Medical Inc. (PRVCF), closed the day's trading session at $0.03, up 29.87%, on 577,552 volume with 45 trades. The average volume for the last 3 months is 655,347 and the stock's 52-week low/high is $0.002/$0.20.
- PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Building on Key Milestones in Sol-gel Cannabinoid Development
- NetworkNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Advances Nature Identical Peptides Testing
- PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Deploys Winning R&D Strategy
BLOCKStrain Technology Corp. (TSX.V: DNAX) (OTC: BKKSF)
Liberalization may be bringing cannabis consumption out of the shadows, but large parts of the supply chain remain hidden – an inconspicuous circumstance that poses great risk to consumers. In New Haven, Connecticut, about 100 people overdosed on “synthetic marijuana” recently, and they may have had no idea that their pot was “synthetic.” Synthetic marijuana can be made to look like the real thing. Technology from BLOCKStrain Technology Corp. (TSX.V: DNAX) (OTC: BKKSF) may have saved these unfortunate individuals from such dire straits. The company’s blockchain system can accurately track all stages of the cannabis supply chain and all aspects of quality control. It could make licensed cannabis retailers and dispensaries as safe as houses.
BLOCKStrain Technology Corp. (TSX.V: DNAX) (OTC: BKKSF), a full-service software company headquartered in Vancouver, BC, Canada, has developed the first integrated blockchain platform that registers and tracks cannabis intellectual property (“IP”) from genome to sale. It is proprietary, immutable and cryptographically secure, thereby establishing a single source of truth for cannabis strains and their ownership.
With Canada set to legalize marijuana use for recreational purposes, and other jurisdictions following suit around the world, new challenges will emerge regarding the ability to provide a safe and legal inventory of a product that up until now was largely only available on the black market. Cannabis will be heavily tested and regulated by numerous regulatory bodies in Canada. The cannabis industry faces unique challenges that BLOCKStrain specifically helps it address, including:
- Mandatory Testing: Through BLOCKStrain’s platform and lab-testing partners, the process is more efficient and streamlined, cutting the administrative burden in half and getting products to market faster;
- DNA Based Product Validation: The underlying blockchain technology creates a genetic fingerprint that identifies and validates the product electronically so any participant on the platform, including consumers, can view and track what’s happening with that product from genome to sale;
- Intellectual Property: Third, and perhaps most importantly, the BLOCKStrain platform protects the intellectual property of growers and breeders. This is important for the industry’s growth as products evolve and develop. If a craft grower, for example, creates a popular strain with unique characteristics, it will be able to protect its intellectual property by simply registering the strain’s genome with BLOCKStrain and locking that data into the blockchain. It will reside there forever and will be readily accessible in the event of future disputes, bringing a level of trust to the industry and ensuring licensing fees are paid to all players in the market.
VERIFICATION = CERTIFICATION
BLOCKStrain’s genetics verification process is authentic and incredibly effective. User groups register by creating an account with BLOCKStrain, which starts the process. Organizations and independent growers submit seeds, flower and post-extraction product for testing to a registered and approved testing facility, which then submits test results to BLOCKStrain. Pre-existing data of genetic cannabis strains can also be submitted via BLOCKStrain verification administrators, with those results being added to the user group’s blockchain account. Submissions are entered into BLOCKStrain, and the transaction is completed and recorded.
Each time an item is tested and verified by the network, a Registration Affidavit is auto-generated and given a unique “BLOCKStrain Address” along with a traceable QR Code. Producers, patients and consumers are able to not only verify the test but can also rate the product, write reviews and share opinions. This detail is stored within BLOCKStrain and, just like the test results, cannot be tampered with or modified. Verification and certification are earned by all parties for their participation.
SAFE CONSUMER SUPPLY
BLOCKStrain demystifies the seed-to-sale process for all relevant stakeholders including producers, distributors, shippers, government agencies and consumers by creating a repository of cannabis genomes on an immutable, shared ledger. Thousands of cannabis strains exist and cultivators are breeding new strains all the time. The proliferation of cannabis strains can prove problematic for consumers since there are more than 500 known chemical compounds in a single plant. Furthermore, since several dozens of these compounds have been identified as pharmacologically active, it becomes more and more difficult for consumers to know what they are purchasing.
It is for this reason that being able to quantify the genetics, potency and equivalencies among cannabis products is crucial to the future of legalized cannabis. The difference is not so much in the name or brand attached to the cannabis, but the DNA of the plant itself. BLOCKStrain ensures product integrity, safety, regulatory compliance, product licensing and authenticity – all vital elements for the emerging cannabis industry. This technology also bolsters the process of meeting government regulatory standards by providing real-time visibility of industry operations to agencies assigned to enforce and regulate cannabis activity.
INTELLECTUAL PROPERTY RIGHTS
BLOCKStrain allows for the defense of intellectual property rights for the grower with an authentic, verifiable chain of evidence embedded in the blockchain itself. Proof of ownership for a specific strain of cannabis is paramount in a multibillion dollar industry. Real life ownership disputes have already begun in the industry with legal battles underway. Unfortunately, the framework for resolving these disputes has yet to be defined and they are not likely to be resolved anytime soon.
Consumers and regulators alike want to know whether a cannabis product grown and sold at a local dispensary is safe and meets quality control standards. BLOCKStrain enhances trust of origin from genome-to-sale as cannabis flows through the supply chain, verifying critical steps in the process such as who is growing the plant, which seed is planted and where did it come from, whether pesticides were used, how much was grown, which tests are used to establish quality and potency, where the product is transported and how, and whether possession limits are meeting regulatory standards.
In summary, BLOCKStrain has developed the most comprehensive, secure and community-driven cannabis genetics archival platform for cannabis breeders and growers, large and small, to protect and release their varieties into the public domain, all while compensating and rewarding them for their contributions.
BLOCKStrain Technology Corp. (BKKSF), closed the day's trading session at $0.2239, up 17.78%, on 207,261 volume with 24 trades. The average volume for the last 3 months is 48,751 and the stock's 52-week low/high is $0.1099/$0.8500.
- BLOCKStrain Technology Corp. (TSX.V: DNAX) (OTC: BKKSF) Platform Makes Cannabis Consumer Protection Possible
- NetworkNewsBreaks – BLOCKStrain Technology Corp. (TSX.V: DNAX) (OTC: BKKSF) Revolutionizes Visibility, IP Protection in the Cannabis Supply Chain
- BLOCKStrain Technology Corp. (TSX.V: DNAX) (OTC: BKKSF) Delivers Single-Source Accountability in the Cannabis Market
ChineseInvestors.com, Inc. (OTCQB: CIIX) ("CIIX" or "the Company"), the premier financial information website for Chinese-speaking investors, today announces the opening of its new sales and support office in Richmond, British Columbia. The Company's new office, located at 5811 Cooney Road, Suite 305, South Tower, Richmond, BC V6X3M1, is in the heart of Richmond's busy financial district in the Pacific Business Centre, a prime location in close proximity to major Canadian banks, SkyTrain stations, shopping plazas, and the neighboring Service Canada Centre.
Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.
Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.
At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.
CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.
The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.
Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.
In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.
ChineseInvestors.com (CIIX), closed the day's trading session at $0.525, up 6.06%, on 94,949 volume with 87 trades. The average volume for the last 3 months is 257,101 and the stock's 52-week low/high is $0.365/$1.58.
- ChineseInvestors.com, Inc. Expands its Physical Presence With the Announcement of its New Sales Office Location in Richmond, British Columbia, Canada - Offering its Innovative Financial Subscription and Educational Services to Chinese Globally
- ChineseInvestors.com, Inc. (OTCQB: CIIX) CEO on MoneyTV with Donald Baillargeon, 9/14
- ChineseInvestors.com, Inc. (CIIX) Focuses on Providing Financial Information and Services
QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX-V: QMC) (FSE: 3LQ)
QMC Quantum Minerals Corp., (TSX.V: QMC) (FSE: 3LQ) (OTC PINK: QMCQF) (“QMC” or "the Company") is pleased to provide an update on its company’s 100% owned Irgon Lithium Mine Project located within the prolific Cat Lake-Winnipeg River rare-element pegmatite field of S.E. Manitoba, which also hosts Cabot Corporation’s nearby Tantalum Mining Corporation of Canada (“TANCO”) rare-element pegmatite.
QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX-V: QMC) (FSE: 3LQ) is a British Columbia based company engaged in the business of acquisition, exploration and development of natural resource properties. QMC’s focus is on creating shareholder value through strategic acquisition and development of high quality lithium, silver, gold, nickel, copper and zinc prospects.
QMC’s current properties are in the Canadian province of Manitoba, one of Canada’s most productive, centrally located mining regions. These resources include the Irgon Lithium Mine project and two Volcanic Massive Sulphide (“VMS”) properties – the Rocky Lake and Rocky-Namew known collectively as the Namew Lake District Project – which contain base metal-rich mineral deposits. Excellent access and well-developed mining infrastructure to the company’s wholly-owned Irgon Lithium Mine Project offers significant value and ramps up the near-term production schedule, putting QMC in a position to take advantage of rising lithium prices.
The region’s historic resource estimate of lithium is well documented in a 1956 Assessment Report developed by a previous owner, Lithium Corporation of Canada Ltd. The project’s historical resource estimate of 1.2 million tons grading 1.51% lithium-oxide over a strike length of 365 meters and to a depth of 213 meters is being updated by QMC through a detailed channel sampling and subsequent drill program.
North Face Software Ltd. recently created an interactive 3-D model of the Irgon Dike utilizing all historical data derived from past drilling and underground work. The 3-D model clearly demonstrates that exploration and underground development has only taken place on the central portion of the dike, leaving significant potential to quickly increase tonnage.
The company’s latest assay results, obtained from 144 channel samples at QMC’s Irgon Lithium Mine Project, provided encouraging and positive results that compare favorably with the historic assays. QMC has received a drill permit from the Sustainable Development Office of the Manitoba government and is in the process of requesting and assessing bids from drilling contractors. The company plans to begin a 2,000-meter drill program to confirm the historic lithium oxide assay results documented in the historic 1953-54 drill program.
QMC’s experienced leadership team includes specialists in mineral exploration, geology, engineering, new business development, marketing and investor relations. The company’s team of qualified advisors includes consultant Bruce E. Goad, P.Geo., who has 40 years of experience in mineral exploration in Canada, Argentina, Asia and Africa. As a Qualified Person, Goad has worked on numerous deposit styles including rare element pegmatites, porphyry, banded iron formation (BIF) gold deposits, skarn, greisens, and VMS. He has a wide and varied skill set which includes precious, base, industrial and rare metal projects with a sharp focus on gold exploration. Goad is the author of several scholarly publications on pegmatite granites of the southeastern Manitoba region.
The market for lithium has surged over the past three years with prices per metric ton tripling. The world’s rising demand for portable power can easily been seen in the electric vehicle and mobile device industries – both of which use lithium-based, renewable batteries as a power resource. QMC’s high potential prospects and experienced management team, both in geology and corporate finance, put QMC and its shareholders in an excellent position to take advantage of the lithium, precious and base metals markets.
QMC Quantum Minerals Corp. (QMCQF), closed the day's trading session at $0.275, off by 3.98%, on 87,745 volume with 22 trades. The average volume for the last 3 months is 94,952 and the stock's 52-week low/high is $0.0005/$0.0299.
- Drill Program Update: QMC and SGS Canada Commence MMI Survey
- NetworkNewsBreaks – QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) Optimistic on Favorable Lithium Pricing Outlook
- NetworkNewsBreaks – QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) is Fired Up to Power the New Age with Battery Safety Improvements on the Horizon
Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF)
NetworkNewsAudio announces the Audio Press Release (APR) titled "New Technologies May Turn Arkansas into a Lithium Superpower," featuring Standard Lithium Ltd. (TSXV: SLL) (FRA: S5L) (OTCQX: STLHF). To hear the NetworkNewsAudio version, visit: http://nnw.fm/Wjy7L. To read the full editorial, visit: http://nnw.fm/aj6bZ.
Standard Lithium Ltd. (OTC: STLHF) is focused on unlocking the value of existing large-scale U.S.-based lithium brine resources that can quickly be brought into production. The Company believes new lithium production can rapidly be brought on stream by minimizing project risks at selection stage; resource, political & geographic, and regulatory & permitting; and by leveraging advances in lithium extraction technologies and processes.
The Company’s flagship project is in southern Arkansas. The more than 180,000-acre “Smackover Project” is in the most prolific and productive brine processing region in North America. Agreements with large commercial brine operators in the region will allow Standard Lithium to utilize the extensive existing infrastructure, including brine supply and disposal pipelines, water, power and a trained workforce to fast-track project development timelines.
“Arkansas produces about 9.4 billion gallons of brine per year, according to 2010-2016 average statistics reported by the Arkansas Oil & Gas Commission.”
Standard Lithium signed a binding MoU with global specialty chemicals company LANXESS Corporation and its U.S. affiliate Great Lakes Chemical Corporation with the purpose of demonstrating the commercial viability of extraction of lithium from brine (“tail brine”) that is produced as part of LANXESS’ bromine extraction business at its three Southern Arkansas facilities.
LANXESS’ land operations in Southern Arkansas encompass more than 150,000 acres, 10,000 brine leases and surface agreements and 250 miles of pipelines. LANXESS extracts the brine from its wells located throughout the area, and the brine is transported to the three Arkansas plants through a network of pipelines. The three bromine extraction plants currently employ approximately 500 people and process and reinject several hundred thousand barrels of brine per day.
Standard Lithium has developed a breakthrough rapid lithium extraction process that reduces the recovery time of extracting lithium from brine to as little as several hours vs. the current industry method that takes years. The process is also much more environmentally friendly with a significantly smaller footprint than the conventional processes. The company has a signed agreement to locate a demonstration scale lithium extraction plant inside one of LANXESS’ chemical plants in Southern Arkansas.
The Company has also signed an option agreement with NYSE-listed Tetra Technologies for the lithium rights for exploration, extraction, and possible commercial development on approximately 30,000 acres of brine leases in Southern Arkansas. The largest available land package.
Recent laboratory results of four brine samples recovered from two existing wells in Standard Lithium’s project area showed lithium concentrations ranging between 347-461 mg/L lithium, with an average of 450 mg/L lithium in one of the wells and 350 mg/L in the other. Geological modeling of the project area is complete, and a maiden resource report is on the horizon.
World demand for lithium continues to surge. The global lithium compounds market is projected to reach U.S. $5.87 billion by 2020 at a compound annual growth rate of 13.22% between 2015 and 2020. Lithium-ion batteries are the fastest growing segment of the market.
Standard Lithium’s commitment to being a premier, innovation-driven company focused on developing and commercializing new modern processes for lithium extraction is bolstered by the leading experts that comprise the company’s Scientific Advisory Council. Each member was selected because of their experience and expertise in areas that are central to and/or complement Standard Lithium’s current development plans. Standard Lithium recently welcomed to the Council world-renowned chemist Dr. Barry Sharpless, the recipient of the 2001 Nobel Prize in Chemistry for his work on chirally catalyzed oxidation reactions.
Standard Lithium is led by a team of professionals with proven strong technical and project development skills. CEO Robert Mintak has a global network of industry contacts and is a pioneer in the rapidly evolving lithium space. COO and President Dr. Andy Robinson is an experienced geoscientist with 20+ years of experience and a PhD in Geochemistry from the University of Bristol, UK. Dr. Robinson has worked on a wide range of projects in the resource, power and energy sectors in Europe, Africa, and North and South America.
The company recently appointed Robert Cross as non-executive chairman. Cross is an engineer with 25 years of experience as a financier and company builder in the mining and oil and gas sectors. He co-founded and serves as chairman of B2Gold, a top-performing growing gold producer which is expected to achieve nearly 1 million ounces of low-cost gold production in 2018. He was also co-founder and chairman of Bankers Petroleum Ltd.; co-founder and chairman of Petrodorado Energy Ltd.; and until October 2007 was the non-executive chairman of Northern Orion Resources Inc. He also was previously the chairman and CEO of Yorkton Securities Inc., and a partner in investment banking with Gordon Capital Corp. in Toronto. Cross has an engineering degree from the University of Waterloo (1982) and received an MBA from Harvard in 1987.
Following a multi-million-dollar financing in Q1 2018, Standard Lithium is well-positioned to meet its upcoming milestones including two maiden resource reports and the launch of its breakthrough rapid lithium extraction technology.
Standard Lithium Ltd. (OTC: STLHF), closed the day's trading session at $1.14, off by 1.72%, on 28,510 volume with 42 trades. The average volume for the last 3 months is 34,724 and the stock's 52-week low/high is $0.60409/$2.23.
- NetworkNewsAudio Announces Audio Press Release (APR) on Standard Lithium Ltd. Leveraging Rapid Process, Quick Execution in a Fast-Track to Commercial Production
- NetworkNewsWire Announces Publication on Lithium Suppliers to Reap Rewards of Major Paradigm Shift in Car Industry
- New Technologies May Turn Arkansas into a Lithium Superpower
DPW Holdings, Inc. (NYSE American: DPW)
DPW Holdings, Inc. (NYSE American: DPW), a diverse holdings company, last week announced that it has filed a prospectus supplement with the Securities and Exchange Commission for a continuous public offering of up to one million shares of its newly designated 10% Series A Cumulative Redeemable Perpetual Preferred Stock carrying liquidation preference of $25.00 per share. To view the full press release, visit: http://ccw.fm/FNw3k.
DPW Holdings, Inc. (NYSE American: DPW), is a diverse holding company pursuing a growth strategy of acquiring undervalued assets with disruptive technologies with a global impact.
The company invests in diverse industries within the commercial, defense/aerospace, industrial, communication, medical, crypto-mining, hospitality, textile, and corporate investment/lending sectors. DPW has evolved and grown from being a leader in advanced power products. Through its subsidiaries, the company continues to be a leader and supplier of innovative technologies, advanced design and development services, and state-of-the-art power products and solutions.
Through its wholly owned Coolisys Technologies, Inc. subsidiary, DPW is committed to offering world-class technology-based solutions for critical applications and lifesaving services that are primarily driven by innovation. Coolisys targets to the defense, aerospace, naval, homeland security, medical, telecom, datacom and industrial markets. Its growth strategy centers on core markets that are characterized by “high barriers to entry” and require specialized products and services not likely to be commoditized. Through a portfolio of companies, Coolisys is engaged in developing and manufacturing advanced switching power products and power solutions that utilize a customized digital power management and resonant topology to attain:
- The highest efficiency and highest density power converters and inverters
- Specialized complex airborne high-frequency, radio frequency (RF), and microwave detector-log video amplifiers (DLVA)
- Very high-frequency filters
- Naval power conversion and distribution equipment
Coolisys offers its technology and services through three primary groups: the Power Solutions Group (PSG), the Defense and Aerospace Solutions Group (DSG), and the Advanced Service Industries (ASI) Group. Coolisys manages five divisions:
- Digital Power Corporation, a leader in providing power electronics technology that is based in northern California.
- Digital Power Limited dba Gresham Power Ltd, a designer and manufacturer of power distribution systems primarily for Naval use that is based in Salisbury, UK.
- Microphase Corporation, a designer and manufacturer of microwave electronics technology that is based in Shelton, Connecticut.
- Power-Plus Technical Distributors, a value-added distributor that is based in Sonora, California.
- Enertec Systems, a developer and manufacturer of specialized advanced electronic systems for the defense and aerospace sectors that is based in Karmiel, Israel.
DPW’s portfolio of wholly owned subsidiaries also includes Digital Power Lending, LLC (DPL), a California private lending company operating under Financial Lender’s License ##60DBO-77905. DPL is dedicated to strategically providing capital to small and middle-size businesses for an equity interest in addition to loan fees and interest. DPL provides secured and unsecured debt financing for public and private companies. These loans will typically have a six to 12-month maturity and range from $250,000-$5 million. DPL is active in bridge loans, receivable financing, inter company loans and micro loans. DPL will work with a network of company owned ATMs (terminals) in California, which will help utilize its CA Finance Lending License and enable the company to offer micro loans of up to $500 or less.
Management has over 50 years of Wall Street experience of investing in, and building companies. DPL’s desire is to bring world-class companies lending opportunities while allowing main street investors to participate. Deal flow and organization comes from an extensive network of investment bankers, business brokers, family offices, and institutional clients enabling DPL to engage and fund the most compelling companies from Silicon Valley to Wall Street.
To date, DPL has funded over $19 million in loans. Since inception, DPL has internally funded over $15 million to DPW’s portfolio companies and wholly owned subsidiaries. As for companies outside DPW, DPL has lent over $4 million in commercial and real estate loans. DPL has funded INVO Bioscience, Medovex, Parallax, Alzamend Neuro, as well as hospitality clients, such as Guilia DTLA and Prep Kitchens.
Another subsidiary wholly owned by DPW is Super Crypto Mining, Inc., a cloud computing service that provides shared and managed computing resources optimized for various block chain mining solutions. Based in Newport Beach, California, Super Crypto Mining leverages its engineering expertise and existing locations to create cryptocurrency mining facilities throughout the world. The company owns and maintains the computing resources and sells access to their use. The established mining is on the Top 3 crypto-currencies with the goal of having 10,000 miners deployed in 2018. Super Crypto Mining endeavors to leverage its engineering expertise and existing global facilities (high-security defense business locations) to secure mining farms. Super Crypto Mining is a rapidly growing organization that recently strategically secured 25 mega watts to power the company’s mining farm. For crypto currency mining, locations with inexpensive power and secure capacity are minimal and hence costly. Having such a location allows the company to grow its mining business to more than 20,000 mining machines. Super Crypto Mining continues to purchase mining machines and explore opportunities to expand its services into other related areas including mining farm real estate investments, mining machine development, and mainstream blockchain projects.
DPW additionally has beneficiary ownership in MTIX International, Inc., the parent company of MTIX, Ltd. and I.AM, Inc.
MTIX was acquired by Avalanche International aka MTIX International, Inc., in August 2017 and offers “green technology” that uses a proprietary laser process to enhance the surface of textiles. This process reduces water usage by approximately 75 percent, reduces greenhouse gases by approximately 90 percent, and reduces chemical use by approximately 95 percent.
I.AM, acquired in May 2018, owns and operates hospitality offerings that include four Prep Kitchen brand restaurants and Giulia DTLA.
Utilizing a shareholder-centric approach to compensation, DPW has formulated the following 10-year objectives:
- Achieve compounded annual revenue growth of 25-35%
- Achieve compounded annual net Income growth of 5%
- Achieve positive unrestricted free cash flow by the end of 2019
DPW is led by a seasoned team of successful business professionals and entrepreneurs. The company is headquartered in Newport Beach, California.
DPW Holdings, Inc. (DPW), closed the day's trading session at $0.4242, off by 6.77%, on 887,558 volume with 1,437 trades. The average volume for the last 3 months is 1,783,668 and the stock's 52-week low/high is $0.3889/$5.949.
- CryptoNewsBreaks – DPW Holdings, Inc. (NYSE American: DPW) Outlines Upcoming $25 Million Public Offering
- DPW Holdings Announces $25 Million Public Offering of 10% Series A Cumulative Redeemable Perpetual Preferred Stock
- DPW Holdings Terminates the At Market Issuance Sales Agreement
Sugarmade, Inc. (SGMD)
Sugarmade, Inc. (OTC: SGMD) is targeting the European hydroponics market, supplying multiple products for cultivators via its first order through the Amazon UK program. Its agreement calls for it to offer several dozen stock keeping units (SKUs) to be sold in the United Kingdom. A cannabis-related supply company, SGMD projects that its 2019 volume will reach $30 million at operating profitability (http://nnw.fm/b7bWf).
Sugarmade, Inc. (SGMD) one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include: ZenHydro.com; CarryOutSupplies.com; and BudLife. Headquartered in Monrovia, California, a city within Los Angeles county, Sugarmade has various business operations in diverse marketplaces including packaging and paper goods for various industries, agricultural supplies.
Sugarmade has expanded into the European hydroponics supply market with a growing base of orders taken through Amazon UK. Over the past few financial quarters, Sugarmade has seen revenue growth patterns expand geographically. As recently as mid-2017, the majority of hydroponic-related revenue growth was seen from California and other West Coast marketplaces, however growth is becoming more geographically dispersed among U.S. states where legalization has eased restriction. This movement into the United Kingdom further expands the base of geographic growth areas for Sugarmade.
Sugarmade recently launched a new corporate initiative in the booming industrial hemp and CBD, committing up to $1 million in capital over the next 12 months to invest in Hempistry, Inc., a privately held Nevada corporation. Hempistry has begun planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 23,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3 percent of THC, the psychoactive ingredient found in cannabis. The U.S. hemp industry is expected to produce well over $1 billion in revenues in 2018, with a compound annual growth rate of 14 percent through 2022, according to the Hemp Business Journal.
Demand for industrial hemp and products derived from hemp is soaring, with no let-up in sight, which the company sees as a “tremendous opportunity to become a supplier to this fast-growing sector,” said Chairman and CEO Jimmy Chan, who is also an advisor and minority shareholder of Hempistry.
Sugarmade’s investment into the market for high-CBD hemp is expected to be highly accretive for common shareholders in two ways. First, Sugarmade’s investment will be in the form of common shares in Hempistry allowing Sugarmade common shareholders to possibly benefit from any future initial public offering of Hempistry. Second, Sugarmade is expected to sign a supply agreement with Hempistry for cultivation supplies, which would be additive to corporate revenues.
Sugarmade has also completed a master market agreement with industry leader BizRight Hydroponics, Inc., a leading marketer and manufacturer of cannabis and hydroponic growth supplies, which offers a range of hydroponics-related products including: HPS grow lights, electronic ballasts, HPS bulbs, nutrient mixes, environmental control products, pH measurement and calibration solutions and storage products. BizRight operates the ZenHydro.com website and other e-commerce properties and sells various products to distributors and retailers. BizRight is expected to produce in excess of $30 million in revenues during 2017, with substantial growth expected for 2018.
Sugarmade division CarryOutSupplies.com, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30-40 percent of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.
CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.
Arman Tabatabaei serves as operations consultant, providing high-level, day-to-day strategic guidance and tactical operational supervision for all aspects of the corporation’s business. He is an expert at data collection and analysis relative to resource management, risk forecasting and profit and loss management.
Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base.
Sugarmade, Inc. (SGMD), closed the day's trading session at $0.116, off by 0.27%, on 2,831,009 volume with 267 trades. The average volume for the last 3 months is 1,186,936 and the stock's 52-week low/high is $0.028/$0.43.
- Sugarmade, Inc. (SGMD) Eyes European Hydroponics Supply Growth in Europe, Projected to be a €115 Billion Cannabis Market by 2028
- Cannabidiol (CBD) Infusion into Healthcare Products Industry Growing Faster Than Expected
- SeeThruEquity Initiates Coverage on Sugarmade, Inc.
TMSR Holding Company (NASDAQ: TMSR)
TMSR Holding Company Limited (NASDAQ: TMSR), a company that through its subsidiaries develops, produces and sells patented industrial and mining waste management solutions, has announced changes in the membership of its board of directors. Two directors, Yaqing Hu and Hui Zhu, have resigned from their roles on the board due to personal reasons. Their resignations took effect at the end of August, according to a company news release (http://nnw.fm/iJHr6).
TMSR Holding Company (NASDAQ: TMSR), together with its subsidiaries, is a recognized leader in the research, development, production and sale of solid waste recycling systems and zero emissions process systems, for the industrial and mining sectors in the People’s Republic of China. The company operates through its wholly owned business divisions: Shengrong Environmental and Wuhan HOST Coating Materials.
TMSR’s Shengrong subsidiary designs, builds, sells and services customized solid waste recycling systems and equipment for some of the largest industries in China. The company provides customers full-service, tailor-made systems from conceptual design to planning, production, modernization, optimization, assembly, start-up, conversions, disassembly, maintenance and servicing of components to complete zero emissions solid waste recycling and process systems.
Utilizing what management believed to be the world’s most advanced technologies of physical magnetic industrial solid waste recovery, Shengrong can process a variety of industrial solid waste materials and is able to extract valuable metal byproducts from the waste without generating any chemical pollution. Shengrong’s patented equipment can process aluminum slag, copper mine tailings, iron mine tailings, red mud manganese tailings, and molybdenum tailings among many others. Unlike traditional chemical-based recovery methods, the company extracts resalable metals from the waste without generating any pollution. The residues are processed to manufacture high-quality construction materials, turning polluted solid waste into valuable industrial materials with zero discharge.
Industrial solid waste recycling and heavy metal removal are significant worldwide technical, financial and environmental issues. Through Shengrong, TMSR is addressing this profound unmet market need by delivering end users a clean alternative to traditional waste disposal. The company intends to leverage these serious unmet needs, expand its patented industrial waste recycling systems to broad international markets, and provide global industrial and mining businesses cost-effective, patented green technology platforms that create new-found revenue streams for end users.
Through Shengrong, TMSR owns two U.S. patents and five patents granted by the Peoples Republic of China, including four invention patents and two utility model patents. The company’s research and development efforts have achieved technological advancements that allow end users to eliminate pollutant discharge as well as generate new revenue streams by selling valuable byproducts extracted from industrial waste.
TMSR subsidiary, Wuhan HOST Coating Materials, is the largest manufacturer of inorganic Zinc-rich resin and one-component epoxy Zinc-rich resin in China. Established in 2010, Wuhan HOST is a leader in the research and development, production and sale of Zinc-rich coating materials throughout the PRC and has a broad customer base that includes some of the foremost enterprises in major industries such as electricity, metallurgy, machinery, chemicals, bridge and shipping. TMSR completed the acquisition of 100% equity interest in Wuhan HOST Coating Materials on May 1, 2018.
Notably, TMSR first went public as JM Global Holding Company, a Special Purpose Acquisition Company (SPAC) formed to effect a merger, asset acquisition or other business combination that had exceptional growth potential. After reviewing over 50 potential targets and completing due diligence and third party analysis, JM Global identified China Sunlong Environmental Technology Inc. and its wholly owned subsidiaries as the acquisition target. Upon closing the business combination, the company was re-named TMSR Holding Company Ltd.
Demand for TMSR’s products is expected to grow significantly due to Chinese policies that encourage mining and manufacturing companies to adopt “green” technology. Approximately 3 billion tons of industrial solid waste were generated annually in China between 2011 through 2015. Currently, 95% of industrial solid waste in China is stored in special facilities and sites; however, the cost of storage, disposal and incineration of industrial solid wastes is high. TMSR is focused on exploiting this unmet need, providing end users in the solid waste recycling markets a clean alternative to traditional waste disposal, significantly reducing solid waste discharge into the environment and enabling end users to extract value from industrial waste materials.
TMSR Holding Company (TMSR), closed the day's trading session at $2.6429, off by 9.49%, on 7,307 volume with 16 trades. The average volume for the last 3 months is 5,496 and the stock's 52-week low/high is $2.7392/$10.3222.
- TMSR Holding Company Limited (NASDAQ: TMSR) Appoints New Board Members
- NetworkNewsBreaks – TMSR Holding Company Ltd. (NASDAQ: TMSR) Names New Members to Board of Directors
- TMSR Holding Company Limited (NASDAQ: TMSR) working with NetworkNewsWire
Global Payout, Inc. (GOHE)
Global Payout, Inc. (GOHE) provides comprehensive payment solutions that can be fully customized for virtually any domestic and international organization distributing money worldwide. The company is committed to enabling global access to technology for optimizing financial transactions and delivering a global financial eco-system with top-tier banking institutions and the highest level financial technology partnerships.
Today, more than ever before, commercial enterprises and government institutions need powerful financial technology solutions that have the flexibility to deliver innovative customer centric services and drive operational efficiency gains throughout the organization. The Global Reserve Platform is Global Payout’s fully configurable “banking-in-a-box” web-based platform that can fulfill the front-to-back office processing requirements of domestic, foreign exchange and international payment service providers. This platform is designed to improve work flow, operational efficiencies, and global financial management for enterprises operating across the globe.
The Global Reserve Platform can manage practically any financial product, including core and traditional banking products, online banking, card management, mobile wallets, merchant payment processing, biometric payments and authentication management, bill payments and P2P payments, international remittances, government benefits management, loans management, FOREX, and SWIFT / ACH / SEPA payments. Powered by the Global Reserve Administrative module, the platform can be customized for enterprises across a multitude of business sectors.
Investment in financial technology (FINTECH) companies has grown dramatically in recent years with the role of today’s banks shrinking and demand for improved financial solutions continuing to rise. As the industry has continued to expand rapidly, Global Payout’s management team has directed its focus on identifying the most promising market sectors with FINTECH needs. The four core areas selected are logistics, small and medium enterprises (SME), banking and travel.
In 2015, Global Payout introduced MoneyTrac Technology Inc. as a majority owned subsidiary to more effectively focus on the development of financial technologies that specifically address many of the challenges that enterprises in a variety of alternative and “high-risk” market sectors are faced with in processing financial transactions. Powered by Virtu Network Solutions, the MoneyTrac Technology platform is one the most configurable and intuitive financial technology platforms available to alternative and “high-risk” enterprises and provides them with solutions that effectively manages everything from pin debit and virtual currency, to compliance and cash flow logistics.
With the global economy constantly becoming more diversified and connected, Global Payout is well positioned with the technology software solutions its team has developed to address many different needs worldwide. Management has committed itself to exploring and identifying every avenue possible for further establishing itself as a recognized leader in FINTECH solutions.
Global Payout, Inc. (GOHE), closed the day's trading session at $0.0104, up 0.97%, on 3,654,945 volume with 89 trades. The average volume for the last 3 months is 5,415,085 and the stock's 52-week low/high is $0.0099/$0.1599.
- Marijuana Company of America Provides Update on Its Investment in Moneytrac Technology
- MTrac Tech Team Will Attend Big Industry Event August 30-31 in Los Angeles
- CryptoNewsBreaks – Global Payout, Inc. (GOHE) Inks JV Agreement with Representatives of MGR2 to Advocate for MTrac Solution
Sunniva, Inc. (CSE: SNN) (OTC: SNNVF)
Sunniva, Inc. (CSE: SNN) (OTC: SNNVF) is a vertically integrated medical cannabis company operating in the world’s two largest cannabis markets – Canada and California – committed to delivering safe, consistent, high-quality products and services. Sunniva operates through its wholly owned subsidiaries: Sunniva Medical Inc., CP Logistics, LLC, Natural Health Service Ltd., and Full-Scale Distributors, LLC. Sunniva’s vision is to become the lowest cost, highest quality cannabis producer in the markets it serves by building large scale purpose-built cGMP-compliant greenhouses, offering best quality assurance with cannabis products free from pesticides, providing better patient and doctor access to cannabis education, and sourcing better therapeutic delivery devices.
The company is establishing sophisticated distribution channels, including Sunniva’s ownership of Natural Health Services cannabis clinics in Canada with over 95,000 active patients, to purchase the significant quantities of high quality Sunniva-branded and Sunniva private-labeled cannabis products.
Sunniva is an ancient English name which means, “Gift of the Sun.” Sunniva’s team of horticulturists, scientists and engineers is helping to set best practices for the industry, believing that sun-grown, solar-powered cultivation is the most sustainable and cost-effective way to grow high-quality, premium cannabis.
The Sunniva Family includes:
CP Logistics, LLC
Through its subsidiary, CP Logistics LLC, Sunniva is developing Sunniva Campus, a state-of-the-art, purpose-built greenhouse facility in Cathedral City, California. This modern purpose-built, agri-technology greenhouse will adhere to the Current Good Manufacturing Practice (cGMP) regulations that assure proper design, monitoring and control of manufacturing processes and facilities.
Phase 1 of the project includes a fully funded 325,000 square foot greenhouse capable of producing 60,000 kg per year of dry cannabis at capacity with operations commencing Q3 2018. Approximately 30 percent of initial total production will be converted into oils and extracts. Phase 2 is expected to increase the greenhouse by 165,000 square feet and grow production by about 40,000 kg per year.
These uniquely sealed greenhouses are designed to deploy custom, automation assembly line cultivation processes at a large scale. Energy consumption will be reduced while utilizing the energy of the sun and microclimatic controls to provide precise growing conditions. The greenhouse will recirculate air for more efficient climate control, and the company’s Integrated Pest Management System is designed to ensure every plant grown is certified clean and free of all contaminants and pesticides.
Sunniva Medical Inc.
Sunniva Medical Inc. is designing and preparing to break ground on the Sunniva Canada Campus encompassing 700,000 square feet of purpose-built cGMP greenhouse facilities in the Okanagan Valley, British Columbia. The total campus is expected to produce 100,000 kg of premium medical cannabis a year plus additional trim used for extraction. This facility will produce pesticide-free products and will convert trim to extracted products such as cannabis oil that can be used for drug delivery formats such as capsules, dissolvable strips, vaporization cartridges, tinctures and creams.
Sunniva and Canopy Growth Corporation (“Canopy Growth”) recently announced a large take or pay supply agreement. Under the terms of the agreement, Canopy Growth will purchase up to 45,000 kilograms of dried cannabis annually commencing Q1 2019, which includes the distribution of Sunniva branded products. Sunniva Medical is a late-stage applicant under Canada’s ACMPR and is in the final review stage of the process.
Natural Health Services Ltd.
Natural Health Services (“NHS”) owns and operates a network of eight medical clinics in Canada specializing in medical cannabis under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”). NHS connects licensed producers to their 21 physicians and patients with its proprietary SPARK software which utilizes a software-as-a-service revenue model. To date, there are 27 integrated licensed producers utilizing the SPARK software.
In-house physicians specializing in the endocannabinoid system provide expert consultation, education and recommendations for targeted phytoceutical remedies and wellness plans to improve the quality of life for all patients. NHS enjoys a long-term relationship with patients due to the quality of its physician-patient experience. A rapidly expanding NHS cannabis clinic network serves 94,000 active patients in Canada. NHS has also initiated a pilot program with a national pharmacy chain to aggregate more patients.
Full-Scale Distributors, LLC
Full-Scale Distributors, LLC is an industry leading provider of custom, private-label vaporizers through its brand, Vapor Connoisseur. The company currently serves the needs of over 80 top brands in the North American marketplace. Vapor Connoisseur is recognized for its high quality and innovative therapeutic delivery devices. Products are tailored to client needs, ensuring both safety and reliability.
Sunniva’s highly experienced management team is building partnerships with leading scientists, universities and clinical trial groups to deliver proprietary cannabis formulations to a broad spectrum of health ailments and conditions. These global partners require cGMP-certified facilities for the processing and manufacturing of cannabis products. Sunniva is committed to providing safe, pesticide-free, high quality, reproducible cannabis medicines.
Leading Sunniva is co-founder, chairman and CEO Dr. Anthony (Tony) Holler. He is the former CEO and founder of ID Biomedical, which was acquired in 2005 for $1.7 billion by GlaxoSmithKline. He is also the former chairman of Corriente Resources Inc., which was sold for approximately $700 million to CRCC-Tongguan Investment Co. Holler is currently chairman of CRH Medical Corporation, a public company trading on the TSX and NYSE. His expertise includes strategic planning, mergers and acquisitions and financing with a singular focus on increasing shareholder value.
Holler is joined by co-founder Leith Pedersen, who serves as president of Sunniva. Pedersen is the former owner and CEO of Vida Wealth Management Bahamas and was a former investment advisor at Canaccord Wealth Management. He is a former partner and director at JF Mackie and Company, an independent brokerage firm in Calgary, Alberta, that managed capital in excess of $2 billion for high net worth clients. Pedersen’s expertise is in corporate strategy, financing and mergers and acquisitions.
Sunniva, Inc. (SNNVF), closed the day's trading session at $4.75, up 0.42%, on 72,202 volume with 118 trades. The average volume for the last 3 months is 59,912 and the stock's 52-week low/high is $3.609/$16.00.
- NetworkNewsBreaks – Sunniva (CSE: SNN) (OTCQX: SNNVF) Considered Undervalued by Investment Researchers
- NetworkNewsBreaks – Sunniva (CSE: SNN) (OTCQX: SNNVF) Stands Out Among Potential Leading Compliant Producers in California Cannabis Market
- CannabisNewsBreaks – Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) to Provide Ultra-Purified Cannabis Extracts Through White Label Agreement
The QualityStocks Numbers Report
QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.
The QualityStocks Sponsored News
- Accelerated Technologies Holding Corp. (ATHC) Receives Positive Feedback from Intelagy Launch
- Aftermaster, Inc. (AFTM) to Host Shareholder Update Call on August 21, 2018
- American Helium (TSX.V: AHE) (OTC: AHELF) Provides Shareholder Update
- Auscrete Corp. (ASCK) Plans to Commence Production at Flagship Facility by Year-end
- BLOCKStrain Technology Corp. (TSX.V: DNAX) (OTC: BKKSF) Revolutionizes Visibility, IP Protection in the Cannabis Supply Chain
- BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT) Platform Makes Cannabis Consumer Protection Possible
- Cannabis Strategic Ventures, Inc. (NUGS) Fine-tunes Foray into Cannabis Space with Brand Specific Strategies, Acquisitions
- Canopy Rivers Corporation - is “One to Watch”
- ChineseInvestors.com (CIIX) Expands its Physical Presence With the Announcement of its New Sales Office Location in Richmond, British Columbia, Canada - Offering its Innovative Financial Subscription and Educational Services to Chinese Globally
- Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF) Secures 12 Additional Cannabis Retail Opportunities in Alberta and British Columbia
- Consorteum Holdings, Inc. (CSRH) Focusing on Mobile Initiatives
- Cyberfort Software, Inc. (CYBF) in the Process of Acquiring Content Blocking App ‘Just Content’
- CytoDyn Inc. (CYDY) to Hold Investment Community Conference Call on September 13, 2018
- DeepMarkit Inc. (TSX.V: MKT) (OTC: MKTDF) Sees Passion for Gaming in Asia-Pacific Market as Major Opportunity for Global Gamification Strategy
- DPW Holdings, Inc. (NYSE American: DPW) Outlines Upcoming $25 Million Public Offering
- Earth Science Tech, Inc. (ETST) CannabisNewsWire Announces Publication on Superior Hemp-Derived, CBD Formulations Ready for Global Recognition in Nutraceutical, Pharmaceutical Sectors
- FinCanna Capital Corp. (CSE: CALI) (OTC: FNNZF) Issues a Letter to its Shareholders
- First Cobalt Corp. (TSX.V: FCC) (OTC: FTSSF) Acquires 100 Percent Ownership of Promising Idaho Project amid Domestic Cobalt Sourcing Concerns
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Secures Additional Sale of QuadSight™ Prototype
- Global Payout, Inc. (GOHE) Provides Update on Marijuana Company of America Inc. (OTC: MCOA) Investment in Moneytrac Technology
- Green Hygienics Holdings Inc. (GRYN) Announces New Additions to Management Team
- GreenBox POS, LLC (GRBX) Responds to Notice from OTCMarkets
- GTX Corp (GTXO) Norwegian Government Awards GTX Corp Distributor a Two Year contract to Supply GPS Tracking Devices
- Hiku Brands Co. Ltd. (CSE: HIKU) (OTC: DJACF) New Merger Agreement with Canopy Growth and Potential Synergies
- Koios Beverage Corp. (CSE: KBEV) (OTC: KBEVF) Unveils New Beverage Line
- Lexaria Bioscience Corp. (CSE: LXX)(OTC: LXRP) DehydraTECH™ Leverages Need for Speed in Fast-Track Drug Delivery
- Lithium Chile Inc. (TSX.V: LITH) (OTC: LTMCF) to Extend Drilling Depth at Ollague Property
- Marifil Mines Ltd.’s (TSX.V: MFM) (OTC: MFMLF) Lithium Exploration in Argentina is No Cause for Tears
- Marijuana Company of America Inc. (MCOA) CannabisNewsAudio Announces Audio Press Release (APR) on Marijuana Company of America Inc. Preparing for Harvest as Opportunity Ripens in Industrial Hemp
- Medical Cannabis Payment Solutions (REFG) Expands its Reach Within the Legalized Cannabis Sector/a>
- Net Element, Inc. (NASDAQ: NETE) Driving Revenue Through North American Transaction Solutions Segment
- NUGL Inc. (NUGL) Building Deep and Wide to Support Cannabis Consumers’, Companies’ Search Engine Needs
- Pacific Software, Inc. (PFSF) Agri-blockchain Solution Tracks Products from Farm to Table
- Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) Approaches Full Capacity Oil Extraction at Asphalt Ridge Facility
- Phivida Holdings Inc. (CSE: VIDA) (OTC: PHVAF) introduces premium active hemp extract infused functional beverage and supplement line to mainstream retailers in the U.S.
- Pressure BioSciences Inc. (PBIO) Announces Commercial Release of the HUB880 Explorer
- PreveCeutical Medical Inc. (CSE: PREV) (OTC: PRVCF) (FSE: 18H) Building on Key Milestones in Sol-gel Cannabinoid Development
- QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) Drill Program Update: QMC and SGS Canada Commence MMI Survey
- Sharing Services, Inc. (SHRV) Begins Trading on the OTCQB Venture Market
- SinglePoint, Inc. (SING) CEO Discusses LastMile Delivery in Interview on MoneyTV
- Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF) NetworkNewsAudio Announces Audio Press Release (APR) on Standard Lithium Ltd. Leveraging Rapid Process, Quick Execution in a Fast-Track to Commercial Production
- Sugarmade, Inc. (SGMD) Eyes European Hydroponics Supply Growth in Europe, Projected to be a €115 Billion Cannabis Market by 2028
- Sunniva, Inc. (CSE: SNN) (OTC: SNNVF) Considered Undervalued by Investment Researchers
- Teewinot Life Sciences Produces Cannabinoids through Patent-protected CANNSYNTHESIS Technology - QualityStocksNewsBreaks
- The Flowr Corp. Experienced Executive Team Attracts Attention Prior to RTO - QualityStocksNewsBreaks
- The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF) Market Cap Surpasses $2 Billion
- TMSR Holding Company Ltd. (NASDAQ: TMSR) Appoints New Board Members
- TransCanna™ Set to Get Marijuana Moving Across California ‘Pot Desert’ Landscape
- VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) Canna Farms Selected as a Supplier to Ontario Retail Cannabis Market
- WhereverTV Broadcasting Corp. (TVTV) Answers Growing Demand for Exclusive, Over-the-Top TV Streaming Content
- Youngevity International, Inc. (NASDAQ: YGYI) CannabisNewsBreaks – CEO Appointed to Board of Directors of Direct Selling Association
- Zenergy Brands, Inc. (ZNGY) Zero Cost Program Makes Energy Conservation More Accessible
- Zenosense, Inc. (ZENO) MIDS Medical JV to Receive Funding of Up to $1.2 Million
The QualityStocks DailyNetwork Sponsors
About The QualityStocks Daily
The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.
Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.
"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.